Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8

被引:118
|
作者
Shin, S
Lee, Y
Kim, W
Ko, H
Choi, H
Kim, K
机构
[1] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
[2] Nanomed Natl Core Res Ctr, Pohang, South Korea
[3] PNI Inc Ltd, Pohang, South Korea
来源
EMBO JOURNAL | 2005年 / 24卷 / 20期
关键词
caspase-2; caspase-8; PKCK2; priming; TRAIL;
D O I
10.1038/sj.emboj.7600827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although caspase-2 is believed to be involved in death receptor-mediated apoptosis, the exact function, mode of activation, and regulation of caspase-2 remain unknown. Here we show that protein kinase (PK) CK2 phosphorylates procaspase-2 directly at serine-157. When intracellular PKCK2 activity is low or downregulated by specific inhibitors, procaspase-2 is dephosphorylated, dimerized, and activated in a PIDDosome-independent manner. The activated caspase-2 then processes procaspase-8 monomers between the large and small subunits, thereby priming cancer cells for TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. The processed procaspase-8 that is recruited to death-inducing signaling complex by TRAIL engagement becomes fully activated, and cancer cells undergo apoptosis. PKCK2 activity is low in TRAIL-sensitive cancer cell lines but high in TRAIL-resistant cancer cell lines. Thus, downregulating PKCK2 activity is required for TRAIL-mediated apoptosis to occur in TRAIL-resistant cancer cells. Our data provide novel insights into the regulation, mode of activation, and function of caspase-2 in TRAIL-mediated apoptosis.
引用
收藏
页码:3532 / 3542
页数:11
相关论文
共 50 条
  • [1] Q482H mutation of procaspase-8 in acute myeloid leukemia abolishes caspase-8-mediated apoptosis by impairing procaspase-8 dimerization
    Li, Ming
    Yao, Jianfeng
    Zhang, Xiangxi
    Chen, Xuan
    Chen, Juan
    Guan, Yingying
    Yang, Xiaoyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 1376 - 1382
  • [2] Sensitization of human colon cancer cells to trail-mediated apoptosis
    Ambrosio Hernandez
    QingDing Wang
    Stephanie A. Schwartz
    B. Mark Evers
    Journal of Gastrointestinal Surgery, 2001, 5 : 56 - 65
  • [3] Sensitization of human colon cancer cells to TRAIL-mediated apoptosis
    Hernandez, A
    Wang, QD
    Schwartz, SA
    Evers, BM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (01) : 56 - 65
  • [4] Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells
    Theodore O. Garnett
    Maria Filippova
    Penelope Jayne Duerksen-Hughes
    Apoptosis, 2007, 12 : 1299 - 1315
  • [5] Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells
    Garnett, Theodore O.
    Filippova, Maria
    Duerksen-Hughes, Penelope Jayne
    APOPTOSIS, 2007, 12 (07) : 1299 - 1315
  • [6] Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
    Kenya Yamaguchi
    Robert G Uzzo
    Julia Pimkina
    Peter Makhov
    Konstantin Golovine
    Paul Crispen
    Vladimir M Kolenko
    Oncogene, 2005, 24 : 5868 - 5877
  • [7] Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
    Shin, Seoung Woo
    Park, Jeen-Woo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (03): : 723 - 730
  • [8] Chalcones and Dihydrochalcones Augment TRAIL-Mediated Apoptosis in Prostate Cancer Cells
    Szliszka, Ewelina
    Czuba, Zenon P.
    Mazur, Bogdan
    Paradysz, Andrzej
    Krol, Wojciech
    MOLECULES, 2010, 15 (08) : 5336 - 5353
  • [9] Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
    Yamaguchi, K
    Uzzo, RG
    Pimkina, J
    Makhov, P
    Golovine, K
    Crispen, P
    Kolenko, VM
    ONCOGENE, 2005, 24 (38) : 5868 - 5877
  • [10] Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells
    Yoo, Jinsang
    Park, Sung-Soo
    Lee, Yong J.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (05) : 1636 - 1646